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Possible roles of insulin and insulin-like growth factors in rat
preimplantation development: investigation of gene expression by
reverse transcription\p=n-\polymerasechain reaction
X. Zhang, G. M. Kidder, A. J. Watson, G. A. Schultz and
D. T. Armstrong
Departments of 1 Obstetrics and Gynaecology, and Physiology and 2Zoology, The University of
Western Ontario, London, Ontario, Canada; and ^Department of Medical Biochemistry,
University of Calgary, Calgary, Alberta, Canada
The sensitive mRNA phenotyping technique of reverse transcription\p=n-\polymerasechain
reaction was used to demonstrate that insulin receptor mRNA is present in rat embryos
during the preimplantation period. In addition, mRNA encoding insulin-like growth factor(IGF) type I and type II receptors have also been detected in rat preimplantation embryos.
IGF-I mRNA was not detected in preimplantation embryos but was found in oviducts and
uteri of prepubertal and early pregnant rats. IGF-II mRNA was present in both embryos and
in oviducts and uteri during the preimplantation period. These findings suggest that insulin
and IGF-I could influence early embryo development in endocrine or in paracrine fashions,
whereas IGF-II may have an additional autocrine mode of action in affecting preimplantation
embryos in rats.
Introduction
Early embryonic mortality is a significant contributor to
pregnancy failure in many mammalian species (Hafez, 1967;
Cooke, 1988). Prevention of early embryonic mortality requires
a thorough understanding of the regulation of embryo devel¬
opment. Evidence is accumulating that factors promoting the
growth of various types of tissue and cell may also control the
growth of early mammalian embryos (Harvey and Kaye, 1988;
DeChiara et al, 1990; Paria and Dey, 1990). We previously
reported that the addition of insulin to the culture medium
improves the development of rat preimplantation embryos in
vitro, and that this action of insulin requires the presence of
amino acids (Zhang and Armstrong, 1990). The presence of
insulin receptors has been demonstrated in eight-cell mouse
embryos (Heyner et al, 1989). In addition, mRNAs encoding
insulin-like growth factor (IGF) type I and type II receptors and
IGF-II are also present in preimplantation embryos from mice(Rappolee et al, 1990) and cattle (Watson et al, 1992),
suggesting that these receptors may transmit possible embryo-
trophic actions of insulin and IGFs.
A sensitive procedure of reverse transcription—polymerase
chain reaction (RT-PCR) was used to examine the presence or
absence of mRNA encoding insulin receptors in rat preimplan¬
tation embryos to investigate whether the previous observed
beneficial effect of insulin on rat embryos was mediated by
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specific receptor binding. The gene transcripts of IGFs I and II
and their receptors were also examined for their possible
presence in rat embryos and oviducts and uteri (the ligands
only) to establish whether the necessary components exist for
the autocrine or paracrine regulation of early mammalian
development by IGFs.
Materials and Methods
Collection of embryos and reproductive tracts
Prepubertal Sprague-Dawley rats (26—28 days old) from
Charles River Canada (St Constant, Quebec) were induced to
ovulate by s.c. injections of 15 iu eCG and, 56 h later, i.p.
injections of 15 iu hCG. Ovulated oocytes were collected from
oviducts 16—18 h after hCG injections and stripped free of
cumulus cells in 0.1% (w/v) hyaluronidase solution in Ca2 + -,
Mg2 +-free phosphate-buffered saline (PBS). To collect
embryos, the rats were paired with fertile males of the same
strain during the night following hCG injections. Embryos at
one-cell, two-cell, four-cell, morula and blastocyst stages were
collected from oviducts and uteri at 24, 48, 72, 98 and 120 h,
respectively, after hCG injections. The oocytes and embryos
were rinsed extensively in Ca2 + -, Mg2 + -free PBS containing
0.3% (w/v) polyvinyl pyrrolidone and frozen at
—
70°C until
further processing.
Oviducts and uteri were collected from untreated, prepuber¬
tal rats or prepubertal rats at various times after induction of
ovulation and fertile matings as for embryo donors. The
Table 1. Oligonucleotide primers used for RT-PCR
Amplified fragment
Predicted restriction
Gene Size (bp) Site Primer sequence (5'-3')a Reference
Insulin receptor 324 Hindi
IGF Type I receptor 354 Bauli
IGF Type II receptor 186 Heelll
IGF-I 210 Msp\
IGF-II 255 SacII
5' Primer GTCACTGCAGTCATGCGCATGTGCTGG
(nucleotides 3S05-3831)
3' Primer CCGCCCGTTAAGCTTGCCTCCGTTCAT
(nucleotides 4128-4102)
5' Primer ATGCTGTTTGAACTGCAGCGCATGTGCTGG
(nucleotides 3763-3792)
3' Primer CCGCTCGAGCTTGCGGCCCCCGTTCAT
(nucleotides 3116-4090)
5' Primer TGTACACTCTTCTTCTGGCA
(nucleotides 6946-6965)
3' Primer ACAGATGTTGATGTAGAAGACAGG
(nucleotides 7140-7177)
5' Primer GGACCGAGACCCTTTGCGGGG
(nucleotides 184-205)
3' Primer GGCTGCTTTTGTAGGCTTCAGTGG
(nucleotides 393-370)
5' Primer CGCCCCAGCGAGACTCTGTGC
(nucleotides 1142-1162)
3' Primer GCCCACGGGGTATCTGGGGAA
(nucleotides 1396-1376)
Ullrich et al, 1985
Ullrich et al, 1986
Morgan et al, 1987b
Bell et al, 1986
Dull et al, 1984
"Underscored bases indicate mismatches introduced to generate a sticky end restriction site for cloning of PCR fragment. Nucleotide positions in parentheses
indicate the location of the primer sequences relative to published cDNA sequences.
Sequences modified slightly from human cDNA sequence on the basis of sequences in rat IGF-II receptor cDNA (D. Morgan, unpublished).
oviducts and uteri were trimmed free of fat, snap-frozen in
liquid nitrogen and stored at
-
70°C for further processing.
RNA extraction
Oocytes and embryos were pooled according to the stage of
development (about 200 for oocytes, one-cell and two-cell
embryos, or 150 for four-cell, morula and blastocyst stage
embryos) and lysed in 100 µ of lysis buffer (4 mol guanidinium
thiocyanate 1_I; 25 mmol sodium citrate 1_1, pH 7; 0.1 mol
2-mercaptoethanol 1 ~1 and 0.5% (w/v) Sarkosyl). 20 µg of
Escherichia coli rRNA (Boehringer-Mannheim Canada, Laval)
was added to this mixture, which was then layered on to
100 µ of a cushion containing 5.7 mol CsCl 1~ * and 0.1 mol
EDTA 1
~
\ The sample was centrifuged at 247 000 g for 4 h at
20°C, using a TL-100 tabletop ultracentrifuge and TLA-
100 rotor (Beckman Canada, Mississauga), as described by
Rappolee et al (1989). The resultant RNA pellet was dissolved
in 100 µ of 2.5 mol ammonium acetate 1
~
I and precipitated
overnight at
—
20°C after adding 300 µ isopropyl alcohol. The
RNA was pelleted by centrifugation at 10 000 g for 20 min,
rinsed with 70% (v/v) ethanol and left to air-dry.
For oviducts and uteri, the tissue was first homogenized in
the lysis buffer and then layered over CsCl to obtain RNA as
for oocytes and embryos.
Reverse transcription (RT) and polymerase chain reaction (PCR)
Total RNA from 150—200 oocytes and embryos and 0.5 µg
oviductal and uterine RNA were reverse transcribed by incu¬
bation at 42°C for 1.5 h in a 20 µ mixture consisting of
50 mmol Tris l~\ pH 8.3, 60 mmol KCI I'1, 10 mmol DTT
1_ , 3 mmol MgCl2 1 ~ I, 20 ng oligo-dT (Pharmacia Canada,
Montreal) µ "1, lmmol each of dATP, dCTP, dGTP and
dTTP 1
"
J (Pharmacia Canada), 2 U RNAase inhibitor (RNAsin,
Promega, Madison, WI) µ1~ , and 1.5 U avian myeloblastosis
virus reverse transcriptase (Boehringer-Mannheim Canada)
µ ~ . The reaction was terminated by heating at 90°C for
5 min and quickly cooling in ice.
An aliquot (1.0 µ ) of this RT reaction mix was used for PCR
in a final volume of 50 µ containing 10 mmol Tris—HC1 1~ ,
pH 8.3, 50 mmol KCI l~\ 1.5 mmol MgCl2 1~ \ 0.001% (w/v)
gelatin, 0.2 mmol each of dNTP l~ , 1 µ    each of PCR
primers 1 ~1 (see below) and 2.5 U Taq DNA polymer¬
ase (Gibco-BRL Canada, Burlington). The PCR reaction was
covered with 60 µ mineral oil and subjected to 30—40 cycles in
a DNA thermal cycler (Perkin Elmer-Cetus, Norwalk, CT)
where each amplification cycle consisted of denaturing at 94°C
for 1 min, annealing of primers to target sequence at 55-65°C
for 2 min and primer extension at 72°C for 2 min.
An aliquot (15-20 µ ) of the PCR products was analysed by
electrophoresis on 7% polyacrylamide or 2% agarose gels and
Fig. 1. Insulin receptor mRNA in oocytes and embryos. Approxi¬
mately 20 oocytes (O), 20 embryos at one-cell (F) or two-cell (2)
stages, or 15 embryos at eight-cell (8), four-cell (4) or blastocyst (B)
stages were subjected to reverse transcription—polymerase chain
reaction (RT-PCR). The medium in which the oocytes or embryos
were rinsed before RNA extraction was subjected to the same
(RT—PCR) procedures as a negative control (R). A sample of rat kidney
cDNA was included as a positive control (K). The values indicate the
numbers of base pairs for some of the DNA fragments in a 1 Kb DNA
ladder (L). (a) Electrophoresis and ethidium bromide staining of PCR
products after a 30-cycle amplification. The amplification signal was
verified by digestion with HmcII to yield expected fragment sizes of
255 and 69 bp (the latter fragment was not clearly visible in the gel,
probably because of its small size); an example of the digestion of a
PCR product from a one-cell embryo (F) is shown on the left (U: uncut;
C: cut), (b) Southern blot analysis of the gel in (a) using a 32P-labelled
cDNA probe for the human insulin receptor, (c) Electrophoresis
and ethidium bromide staining of PCR products after a 40-cycle
amplification.
stained with ethidium bromide to visualize PCR products on a
UV transluminator. The authenticity of the PCR products with
the anticipated sizes was further verified by either digestion
with restriction endonucleases specific for sequences bracketed
by the PCR primers, or Southern blot analysis after the PCR
products were transferred from an electrophoresis gel to a
nylon membrane, as described by Telford et al (1990a) and
Watson et al. (1992).
The PCR primers used in the present study were designed
and synthesized as reported by Telford et al (1990a) and
Fig. 2. Insulin-like growth factor (IGF) type I receptor mRNA in
oocytes and embryos. A 30-cycle amplification was performed on
samples equivalent to approximately 20 oocytes (O), 20 embryos at
one-cell (F) or two-cell (2) stages, or 15 embryos at four-cell (4),
eight-cell (8) or blastocyst (B) stages. The medium in which the
oocytes or embryos were rinsed before RNA extraction was subjected
to the same reverse transcription—polymerase chain reaction (RT-PCR)
procedures as a negative control (R).
Watson et al (1992). The nucleotide sequences of these primers
are shown in Table I.
Results
All RNA preparations were evaluated by first determining the
presence of a relatively abundant mRNA, ß-actin mRNA,
before the gene of interest was studied. An aliquot of each
RNA preparation was also subjected to the RT—PCR pro¬
cedure, with the omission of reverse transcriptase during the
RT reaction. No amplification product was detected in such
samples using the PCR primers selected for this study (results
not shown). This finding indicates that the amplified signal in
our cDNA preparations was not due to the presence of
genomic DNA.
After an amplification of 30 cycles, a PCR product corre¬
sponding to the insulin receptor mRNA was visualized by
ethidium bromide staining in oocytes, one-cell and two-cell
embryos and blastocysts (Fig. la). Southern blot analysis using
a radiolabelled cDNA probe for human insulin receptor (Ullrich
et al, 1985) confirmed the authenticity of the PCR product, and
also detected insulin receptor mRNA signals in four-cell and
eight-cell embryos (Fig. lb). The presence of low amounts of
insulin receptor mRNA in four-cell and eight-cell embryos
was further demonstrated when the PCR was continued for
40 cycles (Fig. lc).
Messenger RNA encoding the IGF type I receptor was
also detected in oocytes, one-cell and two-cell embryos and
blastocysts (Fig. 2). The signals in four- and eight-cell
embryos were too weak to be visualized easily. This was not
improved by increasing the number of PCR cycles, due to
the presence of a non-specific band (the lower band). This
non-specific band has also been observed in other studies on
mouse and bovine embryos using the same PCR primers(Telford et al, 1990a; Watson et al, 1992), and is caused by a
crossreaction between the primers and insulin receptor cDNA
sequences (Telford et al, 1990a). Differential digestion with
Fig. 3. Verification of polymerase chain reaction (PCR) products. Banll
and Mspl were used to digest PCR products corresponding to
insulin-like growth factor (IGF) type I receptor mRNA (R, 354 bp) and
IGF-I mRNA (L, 210 bp), respectively. L: 1 kb ladder; U: uncut; C:
cut; Em: embryo (Lane O in Fig. 2); Ov: oviduct (Lane Tl in Fig. 4);
Ut: uterus (Lane Ul in Fig. 4). The fragments in the C lane for the
IGF-I receptor represent the uncut insulin-receptor PCR product(324 bp) and fragments from Banll digestion of the IGF-I receptor PCR
products.
Banll (Fig. 3) verified that the upper band (354 bp) represents
the amplification product corresponding to the mRNA encod¬
ing the IGF type I receptor.
IGF-I mRNA was not detected in oocytes or preimplantation
embryos after a 40-cycIe amplification. This was not due to the
failure of the experimental procedures, because in each exper¬
iment a rat kidney sample, included as a control, always yielded
a PCR product corresponding to IGF-I mRNA. Furthermore,
IGF-I mRNA was detected in oviducts and uteri (Fig. 4), and the
authenticity of the PCR product was confirmed by digestion
with Mspl (Fig. 3).
IGF type II receptor mRNA was present in oocytes and
embryos of all stages, and digestion with Haelll produced
diagnostic fragments of the expected size (Fig. 5). IGF-II
mRNA (Fig. 6) was present in oocytes and embryos of all the
stages tested. The PCR product was verified by digestion with
Sedi (Fig. 6).
Discussion
Insulin and IGFs are a group of structurally related polypep¬
tides that regulate the growth of many types of mammalian cell(reviewed by Froesch et al, 1985; and Czech, 1989). The
growth-promoting actions of these polypeptides are mediated
by binding to receptors on the cell membrane, and receptors
with primary binding specificity for the polypeptides have
been identified (reviewed by Baxter, 1988). IGF-I has a higher
binding affinity for the type I receptor than for the type II
receptor, and IGF-II has a higher binding affinity for the type II
receptor than for the type I receptor. Insulin can also interact
with the type I receptor. The present study demonstrates the
presence of mRNA encoding the insulin receptor in preimplan¬
tation rat embryos, and provides supporting evidence that the
previously observed beneficial effect of insulin on rat embryo
development could be mediated through its specific receptor.
The genes encoding IGF type I and type II receptors are also
expressed in rat oocytes and preimplantation embryos at some(for type I receptor) or all stages examined. This suggests that,
as in mice (Dechiara et al, 1990; Harvey and Kaye, 1988), IGFs
also play a role in normal preimplantation development in the
rat by interacting with their specific receptors in the embryo.
IGFs are produced by many tissues of the body and
therefore can act in a paracrine or autocrine fashion in addition
to the endocrine mode of action that is used by insulin
(D'Ercole et al, 1984). Thus, while bloodbome insulin may
transude across the reproductive tract to exert its action on rat
Fig. 4. Insulin-like growth factor (IGF) type I and II mRNA in oviducts and uteri. A 30-cycle amplification was
performed on samples of oviducts (T) or uteri (U) from untreated, prepubertal rats (1), or rats on day 2 (2) or
day 5 (3) of pregnancy (day 1; presence of copulatory plug or spermatozoa in vagina). L: 1 kb ladder.
Fig. 5. Insulin-like growth factor (IGF) type II receptor mRNA in
oocytes and embryos. A 30-cycle amplification was performed on
samples equivalent to approximately 20 oocytes (O), 20 embryos at
one-cell (F) or two-cell (2) stages, or 15 embryos at four-cell (4),
eight-cell (8) or blastocyst (B) stages. The medium in which the
oocytes or embryos were rinsed before RNA extraction was subjected
to the same reverse transcription-polymerase chain reaction (RT—
PCR) procedures as a negative control (R). The PCR products were
verified by digestion with Haelll to yield the expected 152 and 34 bp
fragments (the latter fragment was not clearly visible in the gel,
probably because of its small size); an example of the digestion of a
PCR product from a one-cell embryo (F) is shown to the right of the
1 kb ladder (C). L: 1 kb ladder.
embryos, IGFs that are destined to interact with embryos may
come from the general blood circulation, the reproductive tract
or embryos. The present study did not examine whether insulin
mRNA is present in embryos or the reproductive tract.
However, insulin mRNA was not detected in preimplantation
embryos from mice (Rappolee et al, 1990). IGF-I mRNA could
not be detected in preimplantation embryos in the present
study, which is consistent with the absence of this mRNA in
preimplantation mouse embryos (Rappolee et al, 1990). This
indicates that an autocrine mechanism is not the likely mode of
action for this polypeptide during preimplantation develop¬
ment. The oviduct and uterus are possible sources for IGF-I,
since its mRNA is detected in these two tissues. For IGF-II,
both autocrine and paracrine interactions may mediate its
action since its mRNA is present in preimplantation embryos
and the reproductive tract. The present study did not examine
whether the IGF mRNAs are translated in the reproductive
tract. If these IGF polypeptides are present, their actions on
embryo development would be further regulated by various
IGF binding proteins, which have yet to be studied in this
context.
Preimplantation development of embryos from many mam¬
malian species can be maintained in vitro, independent of the
maternal environment. However, the rate of embryo develop¬
ment in vitro is impaired to various degrees depending on the
species and can be improved by co-culture with oviductal or
uterine cells as well as with some other types of cell (Bavister,
1988). This finding suggests that mammalian embryos have
certain autonomy in regulating their early development, but
that optimal development is obtained by support from their
physiological environment. This hypothesis for the control of
early mammalian development is well supported by the present
Fig. 6. Insulin-like growth factor (IGF) type II mRNA in oocytes and
embryos. A 30-cycle amplification was performed on samples equiv¬
alent to approximately 20 oocytes (O), 20 embryos at one-cell (F) or
2-cell (2) stages, or 15 embryos at 4-cell (4), 8-cell (8) or blastocyst (B)
stages. The medium in which the oocytes or embryos were rinsed
before RNA extraction was subjected to the same reverse
transcription-polymerase chain reaction (RT-PCR) procedures as a
negative control (R). The PCR products were verified by digestion
with SacII to yield expected fragments of 189 and 67 bp; an example
of the digestion of a PCR product from a one-cell embryo (F) is shown
to the right of the 1 kb ladder (C). L: 1 kb ladder.
data on gene expression for the receptors of insulin and IGFs as
well as IGF ligands. Thus, while IGF-II may be a component of
autonomous regulation, IGF-I and insulin are very likely to be
some of the possible maternal regulators of preimplantation
development. Further evidence that insulin plays an important
role in early development comes from experiments in which
mice or rats have been made insulin-deficient through strep-
tozotocin treatment. Blastocysts collected from such diabetic
mothers have fewer cells than do their normal counterparts(Pampfer et al, 1990; Beebe and Kaye, 1991).
Some of the earliest mammalian developmental events are
controlled by maternal products accumulated within the oocyte
during oogénesis. These inherited maternal transcripts undergo
a degradation process to be replaced by transcripts of the
embryonic genome at various species-specific stages of early
cleavage (Telford el al, 1990b). In mouse embryos, the
transition from maternal to embryonic genome control occurs
after the first cell division, and this transition is often reflected
in the changing levels of many mRNA species at the two-cell
stage. For example, the amount of ß-actin mRNA decreases at
the early two-cell stage, as a result of the breakdown of
maternal transcripts in embryos, and increases thereafter as a
result of the activation of the embryonic genome (Giebelhaus
et al, 1983; Graves et al, 1985). In the study by Rappolee et al.(1990), none of the genes that were examined in the present
study was expressed in mouse embryos before the two-cell
stage (i.e. before activation of the embryonic genome), suggest¬
ing that maternal transcripts of these genes are not inherited by
mouse embryos. The results from the present study suggest
that this is not the case for the early rat embryo since maternal
messages for some of the growth factors (i.e. mRNAs encoding
IGF-II and receptors for insulin and IGFs) were observed in
unfertilized rat oocytes and embryos.
Similar differences in the patterns of gene expression were
also reported between bovine embryos and mouse embryos(Watson et al, 1992), suggesting that growth factors may exert
an influence on preimplantation development in many mam¬
malian species earlier than that reported in mice. Although no
definitive evidence is available for the time of activation of the
embryonic genome in rats, it appears to occur after the two-cell
stage as in mice. The low concentration of mRNA encoding the
insulin receptor and IGF type I receptor in four-cell and
eight-cell embryos may be due to a delay in activation of these
genes in the embryonic genome.
This study takes advantage of the highly sensitive RT—PCR
procedure to analyse gene expression in early mammalian
embryos that often cannot be analysed biochemically because
of the scarcity of experimental material. Further studies are
required to verify the translational status of the mRNAs that
are studied in this report. This will help confirm the physiologi¬
cal significance of insulin and IGFs in the regulation of early
embryo development.
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